Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

Authors :: Wolfson, Julie A.
Bhatia, Smita
Ginsberg, Jill
Becker, Laura
Bernstein, David
Henk, Henry (Joe)
Lyman, Gary H.
Nathan, Paul
Puccetti, Diane
Wilkes, Jennifer J.
Winestone, Lena E.
Kenzik, Kelly
Source :: Blood; November 2018, Vol. 132 Issue: Supplement 1 p3531-3531, 1p
Publication Year :: 2018
Abstract: Lyman: Generex Biotechnology: Membership on an entity's Board of Directors or advisory committees; Amgen: Other: Research support; Halozyme; G1 Therapeutics; Coherus Biosciences: Consultancy.

Full Text Access

Tools